World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
32676
World Ranking
12585
National Ranking
135

Overview

Leif Thuesen is affiliated with Aalborg University in Denmark and specializes in the field of Medicine, with a focus on surgery, cardiology and cardiovascular medicine, and radiology, nuclear medicine, and imaging. Their research encompasses subfields including biomedical engineering and pulmonary and respiratory medicine.

The scientist's main topics of work include coronary interventions and diagnostics, cardiac imaging and diagnostics, acute myocardial infarction research, antiplatelet therapy and cardiovascular diseases, advanced X-ray and CT imaging, cardiac, anesthesia and surgical outcomes, and treatments for aortic aneurysm repair.

Frequent publication venues for Thuesen comprise Circulation, EuroIntervention, Open Heart, Cardiovascular Revascularization Medicine, and Cardiology.

  • Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy, 2020, EuroIntervention
  • Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention, 2020, Circulation
  • Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV, 2020, Open Heart
  • Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial, 2021, Circulation
  • Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy, 2021, Cardiology

  • Evald Høj Christiansen (8 coauthored works)
  • Andrejs Ērglis (5 coauthored works)
  • Lisette Okkels Jensen (5 coauthored works)
  • Martin Kirk Christensen (5 coauthored works)
  • Niels Ramsing Holm (4 coauthored works)

Best Publications

  • A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

    Henning R. Andersen;Torsten T. Nielsen;Klaus Rasmussen;Leif Thuesen

  • Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

    Henning Rud Andersen;Jens Cosedis Nielsen;Poul Erik Bloch Thomsen;Leif Thuesen

  • BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS

    J O Jørgensen;S A Pedersen;L Thuesen;J Jørgensen

  • A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

    Patrick W Serruys;John A Ormiston;Yoshinobu Onuma;Evelyn Regar

  • Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study

    Terje K. Steigen;Michael Maeng;Rune Wiseth;Andrejs Erglis

  • Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

    Hans Erik Bøtker;Rajesh Kharbanda;Michael R Schmidt;Morten Bøttcher

  • A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

    John A Ormiston;Patrick W Serruys;Evelyn Regar;Dariusz Dudek

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

    Timo Mäkikallio;Niels R Holm;Mitchell Lindsay;Mark S Spence

  • System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention

    Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen

  • Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes

    Patrick W. Serruys;Yoshinobu Onuma;Dariusz Dudek;Pieter C. Smits

  • Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

    Jens Kastrup;Erik Jørgensen;Andreas Rück;Kristina Tägil

  • Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome

    H.R Andersen;L Thuesen;J.P Bagger;T Vesterlund

  • Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

    Jacob Lønborg;Niels Vejlstrup;Henning Kelbæk;Hans Erik Bøtker

  • Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice

    Keith D. Dawkins;Eberhard Grube;Giulio Guagliumi;Adrian P. Banning

  • A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.

    Patrick W Serruys;Peter Ruygrok;Jörg Neuzner;Jan J Piek

  • A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial

    Patrick W. Serruys;Andrew T. L. Ong;Jan J. Piek;Franz-Josef Neumann

  • In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry.

    Alfredo R Galassi;Salvatore D Tomasello;Nicolaus Reifart;Gerald S Werner

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

    Niels R Holm;Timo Mäkikallio;M Mitchell Lindsay;Mark S Spence

  • Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisClinical Perspective

    Patrick W. Serruys;Yoshinobu Onuma;John A. Ormiston;Bernard de Bruyne

  • Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy.

    Hans Erik Bøtker;Jens Flensted Lassen;Flemming Hermansen;Henrik Wiggers

Frequent Co-Authors

Jens Flensted Lassen
Jens Flensted Lassen University of Southern Denmark
Hans Erik Bøtker
Hans Erik Bøtker Aarhus University Hospital
Patrick W. Serruys
Patrick W. Serruys University of Galway
Henrik Toft Sørensen
Henrik Toft Sørensen Aarhus University
Hector M. Garcia-Garcia
Hector M. Garcia-Garcia MedStar Washington Hospital Center
Dariusz Dudek
Dariusz Dudek Jagiellonian University
Yoshinobu Onuma
Yoshinobu Onuma University of Galway
Stephan Windecker
Stephan Windecker University of Bern
Steen Dalby Kristensen
Steen Dalby Kristensen Aarhus University Hospital
Bernard De Bruyne
Bernard De Bruyne Cardiovascular Center Aalst

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t just mean becoming a physician. Many prospective students consider alternative or complementary pathways—like healthcare administration, nursing practice, or pharmacy—each offering rewarding professional opportunities.

If you’re interested in leadership and want to manage healthcare organizations, a Master of Healthcare Administration (MHA) might be ideal. There are now several options for the cheapest mha programs online for budget-conscious students, as well as a curated list of the cheapest mha programs on-campus or in hybrid format.

Advanced practice nurses may choose a Doctor of Nursing Practice (DNP) for clinical leadership roles. Many institutions now offer most affordable dnp programs that fit around busy work schedules. Meanwhile, the expanding field of pharmacy now includes options for a 3-year online pharmd for aspiring pharmacists looking for flexibility and accelerated graduation.

These online and hybrid programs provide flexible options, reduced costs, and new routes into healthcare careers—opening doors to impact, innovation, and leadership in the U.S. medical system.

Best Scientists Citing Leif Thuesen

Trending Scientists